X
Xinghuan Wang
Researcher at Wuhan University
Publications - 396
Citations - 32903
Xinghuan Wang is an academic researcher from Wuhan University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 42, co-authored 353 publications receiving 25113 citations. Previous affiliations of Xinghuan Wang include Guangdong General Hospital & Research Medical Center.
Papers
More filters
Journal ArticleDOI
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
Dawei Wang,Bo Hu,Chang Hu,Fangfang Zhu,Xing Liu,Jing Zhang,Binbin Wang,Hui Xiang,Zhenshun Cheng,Yong Xiong,Yan Zhao,Yirong Li,Xinghuan Wang,Zhiyong Peng +13 more
TL;DR: The epidemiological and clinical characteristics of novel coronavirus (2019-nCoV)-infected pneumonia in Wuhan, China, and hospital-associated transmission as the presumed mechanism of infection for affected health professionals and hospitalized patients are described.
Journal ArticleDOI
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
Tao Guo,Yongzhen Fan,Ming Chen,Xiaoyan Wu,Lin Zhang,Tao He,Hairong Wang,Jing Wan,Xinghuan Wang,Zhibing Lu +9 more
TL;DR: This case series study evaluates the association of underlying cardiovascular disease and myocardial injury on fatal outcomes in patients with coronavirus disease 2019 (COVID-19).
Journal ArticleDOI
A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)
Ying Hui Jin,Lin Cai,Zhen Shun Cheng,Hong Cheng,Tong Deng,Tong Deng,Yi Pin Fan,Cheng Fang,Di Huang,Lu Qi Huang,Qiao Huang,Yong Han,Bo Hu,Fen Hu,Bing Hui Li,Bing Hui Li,Yi Rong Li,Ke Liang,Likai Lin,Li Sha Luo,Jing Ma,Lin Lu Ma,Zhi Yong Peng,Yunbao Pan,Zhen Yu Pan,Xue Qun Ren,Hui Min Sun,Ying Wang,Yun Yun Wang,Hong Weng,Chao Jie Wei,Dongfang Wu,Jian Xia,Yong Xiong,Haibo Xu,Xiao Mei Yao,Yu Feng Yuan,Tai Sheng Ye,Xiaochun Zhang,Ying Wen Zhang,Yin Gao Zhang,Hua Min Zhang,Yan Zhao,Ming Juan Zhao,Hao Zi,Hao Zi,Xian Tao Zeng,Yong Yan Wang,Xinghuan Wang +48 more
TL;DR: This rapid advice guideline is suitable for the first frontline doctors and nurses, managers of hospitals and healthcare sections, community residents, public health persons, relevant researchers, and all person who are interested in the 2019-nCoV.
Journal ArticleDOI
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19.
Peng Zhang,Lihua Zhu,Jingjing Cai,Fang Lei,Juan-Juan Qin,Jing Xie,Ye-Mao Liu,Yan-Ci Zhao,Xuewei Huang,Lijin Lin,Meng Xia,Ming-Ming Chen,Xu Cheng,Xiao Zhang,Deliang Guo,Yuanyuan Peng,Yan-Xiao Ji,Jing Chen,Zhi-Gang She,Yibin Wang,Qingbo Xu,Renfu Tan,Haitao Wang,Jun Lin,Pengcheng Luo,Shouzhi Fu,Hongbin Cai,Ping Ye,Bing Xiao,Weiming Mao,Liming Liu,Youqin Yan,Mingyu Liu,Manhua Chen,Xiao-Jing Zhang,Xinghuan Wang,Rhian M. Touyz,Jiahong Xia,Bing-Hong Zhang,Xiaodong Huang,Yufeng Yuan,Rohit Loomba,Peter P. Liu,Hongliang Li +43 more
TL;DR: Among hospitalized patients with COVID-19 and coexisting hypertension, inpatient use of ACEI/ARB was associated with lower risk of all-cause mortality compared with ACEi/ARB nonusers, and it is unlikely that in-hospital use ofACEI/ARB wasassociated with an increased mortality risk.
Posted ContentDOI
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chang Chen,Yi Zhang,Jianying Huang,Ping Yin,Zhenshun Cheng,Jianyuan Wu,Jianyuan Wu,Song Chen,Yongxi Zhang,Bo Chen,Bo Chen,Mengxin Lu,Yongwen Luo,Lingao Ju,Jingyi Zhang,Xinghuan Wang +15 more
TL;DR: Among patients with COVID-19, Favipiravir, compared to Arbidol, did not significantly improve the clinically recovery rate at Day 7 and FavipIRavir significantly improved the latency to relief for pyrexia and cough.